Skip to content

PEP for sexual exposure to HIV doesn't lead to more risky sex

Abnormal vaginal Pap smears common in HIV-positive women after hysterectomy

Microbicides pose new challenges for design of research studies

Microbicides 2004 marks new wave of HIV prevention trials

ARV-based HIV microbicides advanced by ground-breaking partnership

Rectal HIV microbicides still a distant prospect

French study shows HAART no benefit against HPV or pre-cancerous anal lesions

Hormonal contraceptive associated with increased risk of HIV infection

CSF abnormalities less likely to normalise in HIV-positive patients treated for neurosyphilis